IFO
ABBV icon

Independent Family Office’s AbbVie ABBV Stock Holding History

Independent Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,157
Closed -$252K – 86
2026
Q1 		$252K Hold
1,157
– – 0.1% 82
2025
Q4 		$264K Hold
1,157
– – 0.11% 71
2025
Q3 		$268K Hold
1,157
– – 0.11% 69
2025
Q2 		$215K Buy
+1,157
New +$215K 0.1% 75

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Independent Family Office's ABBV Position: Q2 2026 in Review

Independent Family Office sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,157 shares — an estimated $252K sold.

Independent Family Office first reported a position in ABBV in Q2 2025 and held it in 4 quarters. The position peaked at $268K in Q3 2025. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Independent Family Office reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Independent Family Office sold 1,157 AbbVie shares in Q2 2026, an estimated $252K.
  • Independent Family Office first reported a position in AbbVie in Q2 2025 and held it in 4 quarters.
  • Independent Family Office's AbbVie position peaked at $268K in Q3 2025.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Independent Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.